Evaluation of vaccines for the prevention of pneumonia in children in developing countries.
about
Use of vaccines as probes to define disease burdenBurden of meningitis and other severe bacterial infections of children in africa: implications for prevention.Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam.The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan children.Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.Rapid assessment tool for Haemophilus influenzae type b disease in developing countries.Immunization against Haemophilus Influenzae Type b in Iran; Cost-utility and Cost-benefit Analyses.Impact of introduction of the Haemophilus influenzae type b conjugate vaccine into childhood immunization on meningitis in Bangladeshi infantsEconomic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya.Pneumonia's second wind? A case study of the global health network for childhood pneumoniaIncidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillanceImmunoblot method to detect Streptococcus pneumoniae and identify multiple serotypes from nasopharyngeal secretions.Pyruvate formate lyase is required for pneumococcal fermentative metabolism and virulence.Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate)Natural materno-fetal transfer of antibodies to PspA and to PsaA.The radiological diagnosis of pneumonia in children
P2860
Q30217266-61E9AFE0-8395-4AA6-9168-2018BB6FD628Q34102333-CAC04404-9D6F-4213-A18E-6E588FBEBBD6Q34437804-180DBFC0-4F35-4D83-9465-28A966E2A722Q34540814-27385F52-9D3F-475A-99E4-019D7CC2695BQ35070815-A3D8F029-AA64-47B7-8C8E-9F95E0C98C4CQ35880958-07A21969-0B9A-4D65-98CB-FC3C8F774B94Q36022766-1C5FD98E-DF32-498C-B60A-522EC4035333Q36238741-24A977F9-4D6D-4D63-8405-61D56991ECF7Q37084905-4702CB78-25C5-4C0D-BB83-E7955FDC359CQ37111997-C5B4ED2C-B127-45B9-B93F-D50CC55CE1F1Q37388667-32826BC9-D55C-45E6-90F9-0E60E9D133CCQ37419564-83D2E9AE-2989-40CB-8F0B-7FCB9E04D280Q37451231-19B2B8C1-0220-4026-9C4A-8ADAC3DF0B32Q39508902-967D0234-2D2C-432D-A512-F44915196CD0Q47981601-F2E1678A-5AE3-4653-A2C6-C85A22CC3369Q59117031-3FF9F7EB-6165-4140-AE0D-6748B0996F7C
P2860
Evaluation of vaccines for the prevention of pneumonia in children in developing countries.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Evaluation of vaccines for the ...... ldren in developing countries.
@ast
Evaluation of vaccines for the ...... ldren in developing countries.
@en
type
label
Evaluation of vaccines for the ...... ldren in developing countries.
@ast
Evaluation of vaccines for the ...... ldren in developing countries.
@en
prefLabel
Evaluation of vaccines for the ...... ldren in developing countries.
@ast
Evaluation of vaccines for the ...... ldren in developing countries.
@en
P2093
P1476
Evaluation of vaccines for the ...... ldren in developing countries.
@en
P2093
B M Greenwood
K Mulholland
P356
10.1093/OXFORDJOURNALS.EPIREV.A017987
P577
1999-01-01T00:00:00Z